Solid Biosciences Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Solid Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Solid Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $25.5M, a 8.38% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $25.5M -$2.33M -8.38% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $26.1M -$2.21M -7.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $26.5M -$2.41M -8.33% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $27.2M -$1.26M -4.41% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $27.8M -$1.1M -3.79% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $28.3M +$27.6M +3820% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $28.9M +$27.8M +2435% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $28.4M +$27.2M +2235% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $28.9M +$27.4M +1730% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $722K -$2.47M -77.4% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 $1.14M -$2.44M -68.1% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.22M -$2.73M -69.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $1.58M -$2.73M -63.3% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $3.2M -$1.46M -31.3% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $3.58M -$1.41M -28.2% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $3.95M -$1.58M -28.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $4.31M -$1.31M -23.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $4.66M -$1.26M -21.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $4.99M +$388K +8.44% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $5.53M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $5.62M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $5.92M Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $4.6M Jan 1, 2019 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.